What is the appropriate treatment for scabies lesions on the palmar surfaces of the hands?

Treatment of Scabies Lesions on the Palms

Apply permethrin 5% cream to the entire body from neck down (including palms and soles) and wash off after 8-14 hours, with a repeat application 7-10 days later. 1

Primary Treatment Approach

The CDC STD Treatment Guidelines (2015) establish permethrin 5% as the first-line treatment for scabies, emphasizing full-body application from the neck down 1. This explicitly includes palmar surfaces, which are critical treatment sites.

Key Application Details:

• Apply to ALL body areas from neck down - this specifically includes palms, soles, and interdigital spaces
• Leave on skin for 8-14 hours before washing off
• Repeat the entire application 7-10 days later (second treatment cycle is essential)
• Trim fingernails closely to reduce scratching injury 1

Why Palms Matter in Scabies Treatment

While palmar involvement is classically described in infants and young children, recent evidence shows palms are increasingly affected in older children and adults, particularly with prolonged untreated infestations in tropical climates 2. The palms represent a common site for burrows and active mite infestation, making thorough coverage essential for treatment success.

Common Pitfall - Inadequate Palmar Coverage:

A critical 2026 study demonstrated that standard permethrin regimens frequently fail in palmoplantar scabies due to behavioral factors (hand washing, spontaneous movements) that reduce drug contact time 3. In infants with persistent palmoplantar disease, targeted reapplication to hands and feet for 3 additional nights achieved 100% resolution versus 0% with standard treatment alone.

Alternative Treatment Options

Oral ivermectin 200 mcg/kg, repeated in 2 weeks is an equally acceptable first-line option 1. Ivermectin should be taken with food to increase bioavailability and epidermal penetration. However, permethrin is preferred as it is "effective, safe, and less expensive than ivermectin" 1.

When to Consider Ivermectin:

• Treatment failure with permethrin
• Institutional outbreaks requiring mass treatment
• Patient inability to properly apply topical therapy
• Crusted (Norwegian) scabies (requires combination therapy)

Lindane is NOT recommended except as last resort due to neurotoxicity risk, particularly with application after bathing or in patients with extensive dermatitis 1.

Enhanced Regimen for Palmar Involvement

Based on emerging evidence, consider intensified application for palmoplantar lesions:

• Standard full-body permethrin application (including palms/soles)
• Additional targeted reapplication to hands and feet on consecutive nights if lesions persist 3
• A 2018 study showed two consecutive days of full-body application achieved 87.2% cure rate versus 61.8% with single application 4

Critical Management Steps

Decontamination (Essential to Prevent Reinfection):

• Machine wash and dry all bedding/clothing using hot cycle
• Alternatively, remove items from body contact for 72 hours
• Fumigation is unnecessary 1

Contact Management:

• Examine and treat all household and sexual contacts within the preceding month
• Treat contacts simultaneously to prevent reinfection 1

Follow-Up Expectations:

• Pruritus and rash may persist up to 2 weeks post-treatment - this is normal allergic dermatitis, not treatment failure 1
• Reassess at 2 weeks if symptoms persist
• Consider retreatment if live mites observed or symptoms persist beyond 2 weeks
• Use alternative regimen if initial treatment fails

Special Populations

Pregnant/Lactating Women: Permethrin is preferred; ivermectin classified as "low risk" but limited data 1

Infants/Young Children: Use permethrin only; avoid lindane in children <10 years; ivermectin safety not established in children <15 kg 1

Immunocompromised/HIV: Same treatment as immunocompetent for uncomplicated scabies; higher risk for crusted scabies requiring specialist consultation 1

Treatment Failure Considerations

Persistent symptoms beyond 2 weeks may indicate:

• Faulty application (most common) - particularly inadequate coverage of palms, soles, and interdigital spaces
• Medication resistance
• Reinfection from untreated contacts
• Inadequate decontamination of fomites
• Allergic dermatitis (not active infestation)

For confirmed treatment failure, switch to alternative regimen (permethrin ↔ ivermectin) rather than repeating the same treatment 1.